It has been reported that supplementation with the major human milk oligosaccharides 2-fucosyllactose (2′-FL) and 6-sialyllactose (6′-SL), but not lactose, inhibits TLR4 activation in NEC animal models, protecting against NEC [67]. The gene discussed is TLR4; the disease is necrotizing enterocolitis.